Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revisionBoth sides next revision | ||
news [2023/05/26 07:03] – elviral | news [2023/05/26 07:05] – elviral | ||
---|---|---|---|
Line 4: | Line 4: | ||
X-Research Group - Digital twins for the treatment of hypertension | X-Research Group - Digital twins for the treatment of hypertension | ||
< | < | ||
- | *M. König receives funding of the Berlin University Alliance and the DFG | + | ***M. König** receives funding of the Berlin University Alliance and the DFG |
- | for the X-Student Research Group: Digital twins for the treatment of | + | for the X-Student Research Group: |
- | hypertension* | + | hypertension*** |
Understanding a drugs pharmacokinetics - how it is absorbed, | Understanding a drugs pharmacokinetics - how it is absorbed, | ||
distributed, | distributed, | ||
Line 29: | Line 29: | ||
ATLAS - AI and Simulation for Tumor Liver ASsessment | ATLAS - AI and Simulation for Tumor Liver ASsessment | ||
< | < | ||
- | *The BMBF is funding the joint project ATLAS in the " | + | *The BMBF is funding the joint project ATLAS in the **" |
- | Sciences - AI Methods for Systems Medicine" | + | Sciences - AI Methods for Systems Medicine" |
Liver cancer is the second most common cause of cancer-related death. | Liver cancer is the second most common cause of cancer-related death. | ||
Diagnosis and treatment are time-critical and require highly | Diagnosis and treatment are time-critical and require highly |